Septerna Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Septerna Inc (SEPN)
The Septerna share price today is 43.93, view NASDAQ SEPN stock exchange data. Track the latest Septerna share price with real-time updates on SEPN stock performance including market cap, day range, 52-week range and dividend yield. Access SEPN charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.49
44.93
52 wk Range
10.74
51.10
SEPN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.4944.93
52 wk Range
10.7451.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SEPN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
53.11
Upside
+20.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Septerna Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Top insider buys and sells disclosed on Friday- Investing.com
Septerna Inc stock hits all-time high at 50.0 USD- Investing.com
- Septerna Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Top insider buys and sells disclosed on Friday
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 53.11
(+20.90% Upside)
Earnings
Latest Release
10-08-2026
EPS / Forecast
-0.29 / -0.74
Revenue / Forecast
26.75M / --
Compare SEPN to Peers and Sector
Metrics to compare | SEPN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSEPNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −84.7x | −7.6x | −0.3x | |
PEG Ratio | −1.04 | −0.05 | 0.00 | |
Price/Book | 5.3x | 2.3x | 2.6x | |
Price / LTM Sales | 20.8x | 9.7x | 3.1x | |
Upside (Analyst Target) | 14.2% | 45.7% | 50.4% | |
Fair Value Upside | Unlock | −7.4% | 6.4% | Unlock |
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Septerna (SEPN) Share Price Today?
The Septerna share price today is 43.93.
What is the current Septerna (SEPN) share price and day range?
As of 19-08-2026, the Septerna share price is 43.93, with a previous close of 43.80. The share price has ranged from 43.49 to 44.93 today, while the 52-week range spans from 10.74 to 51.10.
What Is the Septerna Market Cap?
As of today, Septerna market cap is 2.05B.
What Is the Septerna (SEPN) Share Price Target?
The average 12-month share price target for Septerna is 53.11, with a high estimate of 62 and a low estimate of 38. 10 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +20.90% Upside potential.
What Is Septerna's Earnings Per Share (TTM)?
The Septerna EPS (TTM) is -0.54.
When Is the Next Septerna Earnings Date?
Septerna will release its next earnings report on 10-08-2026.
From a Technical Analysis Perspective, Is SEPN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Septerna Trade On?
Septerna is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Septerna?
The stock symbol for Septerna is "SEPN."
How Many Times Has Septerna Stock Split?
Septerna has split 0 times.
How Many Employees Does Septerna Have?
Septerna has 123 employees.
What Is the SEPN Premarket Price?
SEPN's last pre-market stock price is 44.65. The pre-market share volume is 2,430.00, and the stock has changed by 0.85, or 1.94%.
What Is the SEPN After Hours Price?
SEPN's last after hours stock price is 43.11, the stock has changed by -0.82, or -1.86%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.